Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Enlarged liver (hepatomegaly) and Fibro-obliterative bile-duct lesion; and common findings: Portal hypertension, Malformation of the hepatic ductal plate, Jaundice, and Enlarged spleen (splenomegaly). 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 7 | Diarrhea, Enlarged liver (hepatomegaly), Malformation of the hepatic ductal plate |
ZFYVE19 function has not been fully characterized.
Cholestasis, progressive familial intrahepatic, 9 is associated with mutations in the ZFYVE19 gene on chromosome 15.
Genetic testing for ZFYVE19 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cholestasis, progressive familial intrahepatic, 9 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 4 common features.
No clinical trials have been registered for cholestasis, progressive familial intrahepatic, 9.
26 publications have been identified in PubMed for cholestasis, progressive familial intrahepatic, 9. Research spans Review / Meta-Analysis (23%), Case Report / Case Series (23%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
Common questions about cholestasis, progressive familial intrahepatic, 9
Heart and blood vessels | 1 | Portal hypertension |
Skin | 1 | Pruritus |
Metabolism | 1 | Fever |
Blood and immune system | 1 | Enlarged spleen (splenomegaly) |
Patient case studies
6 |
23% |
Disease patterns and progression | 6 | 23% |
Laboratory research | 5 | 19% |
Clinical study results | 2 | 8% |
Testing and diagnosis research | 1 | 4% |
Sciveres M (2026). [PMID: 41718432](https://pubmed.ncbi.nlm.nih.gov/41718432/). *Pediatr Rep*. [Review / Meta-Analysis]
Thunga C (2026). [PMID: 41640953](https://pubmed.ncbi.nlm.nih.gov/41640953/). *World J Hepatol*. [Epidemiology / Natural History]
de Groot ADE (2026). [PMID: 41025998](https://pubmed.ncbi.nlm.nih.gov/41025998/). *Br J Clin Pharmacol*. [Review / Meta-Analysis]
Lk P (2026). [PMID: 41878599](https://pubmed.ncbi.nlm.nih.gov/41878599/). *Oxf Med Case Reports*. [Case Report / Case Series]
Elkoofy NM (2026). [PMID: 40537152](https://pubmed.ncbi.nlm.nih.gov/40537152/). *Clin Genet*. [Case Report / Case Series]
Nigam N (2025). [PMID: 40384941](https://pubmed.ncbi.nlm.nih.gov/40384941/). *J Clin Exp Hepatol*. [Basic Science / Preclinical]
Staut T (2025). [PMID: 41083167](https://pubmed.ncbi.nlm.nih.gov/41083167/). *Acta Gastroenterol Belg*. [Case Report / Case Series]
Vitale G (2025). [PMID: 39984942](https://pubmed.ncbi.nlm.nih.gov/39984942/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Zhou X (2025). [PMID: 41230592](https://pubmed.ncbi.nlm.nih.gov/41230592/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Case Report / Case Series]
Shan D (2025). [PMID: 41232237](https://pubmed.ncbi.nlm.nih.gov/41232237/). *EBioMedicine*. [Epidemiology / Natural History]